|
Australasian Biotechnology (backfiles)
AusBiotech
ISSN: 1036-7128
Vol. 10, No. 6, 2000, pp. 22-24
|
Bioline Code: au00066
Full paper language: English
Document type: Research Article
Document available free of charge
|
|
Australasian Biotechnology (backfiles), Vol. 10, No. 6, 2000, pp. 22-24
en |
BIOTECH LAW - SPECIAL CONSIDERATIONS IN COMMERCIALISING BIOTECHNOLOGY AND HEALTH-CARE PRODUCTS: ROYALTY STACKING AND CO-OWNERSHIP
Adam Liberman
Abstract
This paper is based on a presentation made by Adam Liberman at the Licensing Executives Society of Australia and New Zealand (LESANZ) Annual Conference 2000. That presentation also dealt with issues arising in the context of clinical trials. Those issues are not dealt with in this paper. Adam Liberman is also a past President of LESANZ and a past Chairman of the LESANZ Health Care Group.
|
|
© Copyright 2000 - Australiasian Biotechnology Alternative site location: http://www.ausbiotech.org/content.asp?pageid=16
|
|